中文名稱:Nadunolimab | 英文名稱:Research Grade Nadunolimab(DHJ63401) |
CAS:2171061-85-9 | 純度規(guī)格: PAGE:>95% |
產(chǎn)品類別: 藥物對照抗體 | |
抗體名: Nadunolimab | 靶點: IL-1R3, C3orf13, Interleukin-1 receptor 3, Interleukin-1 receptor accessory protein, IL1RAP, IL-1R-3, IL-1 receptor accessory protein, IL1R3, IL-1RAcP |
宿主: Humanized | 適應物種: Human |
克隆性: Monoclonal | 藥物對照抗體: Nadunolimab |
Tags:Nadunolimab 代理商,Nadunolimab 價格,Nadunolimab 供應商, Nadunolimab supplier,Nadunolimab purchase,Nadunolimab 購買,Nadunolimab 銷售
Catalog No.
DHJ63401
Host species
Humanized
Species reactivity
Human
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Concentration
1 mg/ml
Purity
>95%
Clonality
Monoclonal
Isotype
IgG1-kappa
Applications
Research Grade Biosimilar
Target
IL-1R3, C3orf13, Interleukin-1 receptor 3, Interleukin-1 receptor accessory protein, IL1RAP, IL-1R-3, IL-1 receptor accessory protein, IL1R3, IL-1RAcP
Purification
Protein A or G purified from cell culture supernatant.
Endotoxin level
Please contact with the lab for this information.
Expression system
XtenCHO
Accession
Q9NPH3
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
Alternative Names
CAN-04, CAN04, Nidanilimab, CAS: 2171061-85-9
Note
For research use only. Not suitable for clinical or therapeutic use.
成立日期 | 2021-04-08 (4年) | 注冊資本 | 700萬 |
員工人數(shù) | 100-500人 | 年營業(yè)額 | ¥ 1000萬-5000萬 |
主營行業(yè) | 生物化工,技術服務 | 經(jīng)營模式 | 試劑 |
產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
¥2480 |
VIP3年
|
TargetMol中國(陶術生物)
|
2024-12-12 | |
¥15999.90 |
VIP2年
|
上海阿拉丁生化科技股份有限公司
|
2024-11-29 |